Commit To Buy Galectin Therapeutics At $2.50, Earn 18.9% Annualized Using Options
January 05, 2015 at 11:40 AM EST
Investors considering a purchase of Galectin Therapeutics Inc (GALT) shares, but tentative about paying the going market price of $3.51/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the July put at the $2.50 strike, which has a bid at the time of this writing of 25 cents..